quantifying biomarkers on lambda amyloidogenic light chains to diagnose al amyloidosis
Published 5 months ago • 123 plays • Length 1:55Download video MP4
Download video MP3
Similar videos
-
2:52
assessing the value of various prognostic biomarkers in al amyloidosis
-
2:26
biomarkers of amyloidosis
-
2:19
using ai to predict light chain amyloidosis in patients with mgus and smm
-
0:52
monitoring, diagnosing & managing cardiotoxicity in al amyloidosis
-
1:38
feasibility study of computer vision for quantifying cardiac amyloid burden in biopsies
-
1:44
serum neurofilament light chain as an early disease biomarker in attr amyloidosis
-
11:10
day 1 highlights: peripheral blood mrd, ab amyloid treatment, single-cell & metabolomics
-
18:16
identification of novel biomarkers for thyroid cancer through multi omics data analysis - by. cheena
-
29:29
καρδιακή αμυλοείδωση: διάγνωση, θεραπευτικές επιλογές και αντιθρομβωτική αγωγή | ε. καρβούνη
-
2:20
new prognostic markers in al amyloidosis
-
5:07
daratumumab in the management of al amyloidosis
-
2:38
unmet needs in imaging for the diagnosis of al amyloidosis
-
5:50
amyloid under the microscope (nodular vs systemic amyloidosis al light chain) dermpath pathology
-
7:30
challenges in distinguishing al amyloidosis from attr amyloidosis
-
1:35
vital results for birtamimab in al amyloidosis
-
0:46
an insight into novel measures being explored for the diagnosis of cardiac amyloidosis
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
2:34
the impact of ethnicity on biomarker-based staging in al amyloidosis
-
2:09
the main challenges that remain in diagnosing al amyloidosis
-
2:32
machine learning-based clustering to improve risk stratification in newly diagnosed al amyloidosis
-
3:05
amyloidosis classification and epidemiology
-
1:38
diagnostic and clinical impact of the revised definition of light chain mgus